Cargando…

Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply

Detalles Bibliográficos
Autores principales: Ferrara, Pietro, Antonazzo, Ippazio C., Polosa, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744061/
https://www.ncbi.nlm.nih.gov/pubmed/35006537
http://dx.doi.org/10.1007/s11739-021-02911-9
_version_ 1784630042319388672
author Ferrara, Pietro
Antonazzo, Ippazio C.
Polosa, Riccardo
author_facet Ferrara, Pietro
Antonazzo, Ippazio C.
Polosa, Riccardo
author_sort Ferrara, Pietro
collection PubMed
description
format Online
Article
Text
id pubmed-8744061
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-87440612022-01-10 Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply Ferrara, Pietro Antonazzo, Ippazio C. Polosa, Riccardo Intern Emerg Med Ce - Letter to the Editor Springer International Publishing 2022-01-10 2022 /pmc/articles/PMC8744061/ /pubmed/35006537 http://dx.doi.org/10.1007/s11739-021-02911-9 Text en © The Author(s), under exclusive licence to Società Italiana di Medicina Interna (SIMI) 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Ce - Letter to the Editor
Ferrara, Pietro
Antonazzo, Ippazio C.
Polosa, Riccardo
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply
title Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply
title_full Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply
title_fullStr Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply
title_full_unstemmed Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply
title_short Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply
title_sort response to bnt162b2 mrna covid-19 vaccine among healthcare workers in italy: a 3-month follow-up—reply
topic Ce - Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744061/
https://www.ncbi.nlm.nih.gov/pubmed/35006537
http://dx.doi.org/10.1007/s11739-021-02911-9
work_keys_str_mv AT ferrarapietro responsetobnt162b2mrnacovid19vaccineamonghealthcareworkersinitalya3monthfollowupreply
AT antonazzoippazioc responsetobnt162b2mrnacovid19vaccineamonghealthcareworkersinitalya3monthfollowupreply
AT polosariccardo responsetobnt162b2mrnacovid19vaccineamonghealthcareworkersinitalya3monthfollowupreply